Sort
16,300 grants matching “fatty liver disease”
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2023 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2025 · DK
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2017 · DA
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2019 · DA
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2015 · DA
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm
$733,550Mary E Patti · Joslin Diabetes Center · R01 · FY2023 · DK
Pathogenesis of youth onset pre-diabetes and Type 2 diabetes
$733,481Sonia Caprio · Yale University · R01 · FY2024 · DK
Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH)
$733,441Laura Beretta · University Of Tx Md Anderson Can Ctr · N01 · FY2018 · CA
Understanding the roles of cardiac NAD pools and therapeutic effects of precursor supplements in heart failure
$733,386Joseph A. Baur · University Of Pennsylvania · R01 · FY2022 · HL
Them1-Mediated Metabolic Regulation and Pathogenic Role in MASLD
$733,166David E Cohen · Brigham And Women'S Hospital · R01 · FY2024 · DK
Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy
$733,101Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2025 · DK
Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy
$733,101Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · DK
Risk Stratification for and Early Detection of Liver Cancer
$732,726Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2018 · CA
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification
$732,686Daniel Joseph Cox · University Of Virginia · R01 · FY2022 · DK
Molecular Genetics, Biochemistry And Therapy Of Pathogenic Fungi
$732,572John E Bennett · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Leveraging Large-Scale Multi-Ethnic, Multi-Omic Data for Functional Analysis of Central Obesity Loci
$732,261Stephen S. Rich · University Of Virginia · R01 · FY2025 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
$732,257Lindsey A Miles · Scripps Research Institute, The · R01 · FY2022 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
$732,257Lindsey A Miles · Scripps Research Institute, The · R01 · FY2020 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
$732,257Lindsey A Miles · Scripps Research Institute, The · R01 · FY2021 · HL
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$731,445Andrea A. Kovacs · University Of Southern California · R01 · FY2017 · DA
Mechanisms for regulation of a novel class of anti-diabetic lipids
$731,406Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Physiologic Consequence of Genetic Variation
$731,183Richard M Watanabe · University Of Southern California · R01 · FY2020 · DK
Using genetic variation to study biology of blood lipids & coronary heart disease
$730,677Gina Marie Peloso · Boston University Medical Campus · R01 · FY2024 · HL
Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity
$730,498Jean-Marc Schwarz · Touro University Of California · R01 · FY2025 · DK
Coronary Artery Calcification in Type 1 Diabetes
$730,404Marian J. Rewers · University Of Colorado Denver · R01 · FY2007 · HL